Breast Cancer Clinical Trials

Showing 4981-5000 of 5,597 trials

Neoadjuvant Trial of Capecitabine for Axillary Lymph Node Positive Operable Breast Cancer

NCT02115152

This randomized phase II trial compared pathologic response rates (pCR) of early breast cancer following neoadjuvant fluorouracil-epirubicin-cyclophosphamide(FEC) and capecitabine-epirubicin-cyclophosphamide (XEC).

Stage II Breast CancerStage III Breast Cancer

Guangxi Medical University100 participantsStarted Jun 2014

Nanning, Guangxi, China

COMPLETEDPhase 3

Low Fat Versus Protein Sparing Diet for Weight Loss & Impact on Biomarkers Associated With Breast Cancer Risk

NCT01559194

The primary specific aim of this study was to determine if overweight and obese premenopausal women can lose weight and if long term weight loss impacts biomarkers associated with breast cancer risk.

Breast CancerWeight Loss

Ohio State University Comprehensive Cancer Center82 participantsStarted May 2005

Columbus, Ohio, United States

WITHDRAWNNA

The Effects of Pre-operative Physical Therapy Education

NCT01669187

It is expected that patients who receive physical therapy before surgery will have greater range of motion (ROM), strength, function, satisfaction, and less swelling, pain, and anxiety following surgery compared to those in the control group.

Breast Cancer

Oakland UniversityStarted Dec 2011

Saginaw, Michigan, United States • Saginaw, Michigan, United States

Neoadjuvant Trial of Capecitabine for Axillary Lymph Node Positive Operable Breast Cancer

Low Fat Versus Protein Sparing Diet for Weight Loss & Impact on Biomarkers Associated With Breast Cancer Risk

The Effects of Pre-operative Physical Therapy Education

Related Searches

RAD001 Plus Carboplatin in Breast Cancer Patients

Lifestyle, Exercise and Nutrition Study 1

Phase I/II Study of MK-0752 Followed by Docetaxel in Advanced or Metastatic Breast Cancer

A Prospective Cohort Study to Evaluate the Oncotype DX® Test in Early Stage Breast Cancer

Study of AeroForm Tissue Expander for Breast Reconstruction

Dual Blockage With Afatinib and Trastuzumab as Neoadjuvant Treatment for Patients With Locally Advanced or Operable Breast Cancer Receiving Taxane-anthracycline Containing Chemotherapy

Weekly Gemcitabine and Trastuzumab in the Treatment of Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Metastatic Breast Cancer

Lapatinib+Vinorelbine vs Vinorelbine HER2 Positive Metastatic Breast Cancer Progressed After Lapatinib/Trastuzumab

The Effects of Peri-Operative Pregabalin on Post-Operative Pain Following Breast Cancer Surgery With Axillary Node Dissection: A Pilot Study

Concomitant Chemoradiotherapy With Weekly Paclitaxel and Vinorelbine and Granulocyte Colony Stimulating Factor (GCSF) Support in Patients With Advanced Breast Cancer

IDENTIFICATION OF SENTINEL NODE(S) IN BREAST CANCER

Correlation Between Genetic Variants and Long-term Cardiac Effects Induced by Doxorubicin in Breast Cancer Patients

Docetaxel, Doxorubicin, and Cyclophosphamide in Treating Women With Advanced Breast Cancer

Combination of Oral WX-671 Plus Capecitabine vs. Capecitabine Monotherapy in First-line Her2-negative Metastatic Breast Cancer

Epothilone B in Treating Patients With CNS Metastases From Breast Cancer

A Treatment With Fulvestrant and Exemestane in Postmenopausal Patients With Advanced Hormone Receptor-Positive (HR) + Breast Cancer

Mindfulness-Based Stress Reduction (MBSR) Symptom Cluster Trial for Breast Cancer Survivors